NASDAQ:MLEC Moolec Science (MLEC) Stock Price, News & Analysis → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free MLEC Stock Alerts $1.37 -0.03 (-2.14%) (As of 02:53 PM ET) Add Compare Share Share Today's Range$1.32▼$1.3950-Day Range$1.19▼$2.4752-Week Range$1.15▼$4.40Volume92,523 shsAverage Volume1.28 million shsMarket Capitalization$51.46 millionP/E RatioN/ADividend YieldN/APrice Target$5.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Moolec Science alerts: Email Address Moolec Science MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside307.3% Upside$5.50 Price TargetShort InterestHealthy0.12% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.09 out of 5 starsConsumer Staples Sector124th out of 136 stocksHolding & Other Investment Offices Industry11th out of 13 stocks 3.5 Analyst's Opinion Consensus RatingMoolec Science has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMoolec Science has received no research coverage in the past 90 days.Read more about Moolec Science's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.12% of the float of Moolec Science has been sold short.Short Interest Ratio / Days to CoverMoolec Science has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Moolec Science has recently increased by 56.86%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMoolec Science does not currently pay a dividend.Dividend GrowthMoolec Science does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MLEC. Previous Next 0.6 News and Social Media Coverage Search Interest11 people have searched for MLEC on MarketBeat in the last 30 days. This is an increase of 1,000% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Moolec Science insiders have not sold or bought any company stock.Percentage Held by Insiders19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.07% of the stock of Moolec Science is held by institutions.Read more about Moolec Science's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioMoolec Science has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Moolec Science's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> About Moolec Science Stock (NASDAQ:MLEC)Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.Read More MLEC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MLEC Stock News HeadlinesApril 24, 2024 | msn.comImmutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare moversApril 24, 2024 | seekingalpha.comMLEC Moolec Science SAMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.April 23, 2024 | msn.comTop 2 Risk Off Stocks You May Want To Dump In Q2April 22, 2024 | marketwatch.comMoolec Science Shares Rise 69% After USDA Approval for Plant-Grown Animal ProteinApril 22, 2024 | msn.comWhy Shares Of Moolec Science Are Skyrocketing TodayApril 22, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 121% Today?April 22, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 121% Today?May 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.March 16, 2024 | markets.businessinsider.comVendetti Reaffirms Buy Rating for Moolec Science Highlighting Strong Financials and R&D ProgressFebruary 24, 2024 | msn.comMoolec Science (MLEC) Price Target Increased by 10.00% to 5.61January 11, 2024 | msn.comDown -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)January 11, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 40% Today?December 23, 2023 | wsj.comMoolec Science S.A.December 18, 2023 | investorplace.comMLEC Stock Earnings: Moolec Science Reported Results for Q1 2024December 14, 2023 | msn.comMoolec Science GAAP EPS of -$0.04, revenue of $1.74MDecember 14, 2023 | finance.yahoo.comMoolec Science Presents First Quarter Fiscal Year 2024 Business UpdateDecember 7, 2023 | finanznachrichten.deMoolec Science SA: Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference CallDecember 7, 2023 | finance.yahoo.comMoolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference CallOctober 20, 2023 | finanznachrichten.deMoolec Science SA: Moolec Science Presents Fourth Quarter FY 2023 Business UpdateOctober 20, 2023 | finance.yahoo.comMoolec Science Presents Fourth Quarter FY 2023 Business UpdateOctober 17, 2023 | finance.yahoo.comMoolec Science to Host Fiscal Year 2023 Business Update Conference CallOctober 17, 2023 | msn.comMoolec Science announces capital raiseOctober 17, 2023 | finance.yahoo.comMoolec Science Announces ~US $30 Million Capital Raise With Strategic InvestorsSeptember 27, 2023 | markets.businessinsider.comPromising Future for Moolec Science: A Buy Recommendation Based on Innovative Protein Production and Growth PotentialSeptember 19, 2023 | investing.comMoolec Science SA (MLEC)See More Headlines Receive MLEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today5/08/2024Next Earnings (Estimated)6/12/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:MLEC CUSIPN/A CIK1937737 Webmoolecscience.com Phone650-515-3930FaxN/AEmployees45Year FoundedN/APrice Target and Rating Average Stock Price Target$5.50 High Stock Price Target$6.00 Low Stock Price Target$5.00 Potential Upside/Downside+292.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-51,790,000.00 Net MarginsN/A Pretax Margin-247.39% Return on Equity-69.56% Return on Assets-29.51% Debt Debt-to-Equity Ratio0.89 Current Ratio0.43 Quick Ratio0.37 Sales & Book Value Annual Sales$2.90 million Price / Sales18.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book5.19Miscellaneous Outstanding Shares37,564,000Free Float30,089,000Market Cap$52.59 million OptionableNot Optionable Beta-0.49 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Gaston Paladini M.B.A. (Age 43)Co-Founder, CEO & Director Mr. Henk Hoogenkamp Ph.D. (Age 37)Co-Founder & Chief Product Officer Mr. Martin Salinas Ph.D. (Age 42)Chief of Technology & Co-Founder Mr. Jose Lopez Lecube M.B.A. (Age 41)CFO & Director Mr. Amit Dhingra Ph.D. (Age 54)Chief Science Officer Ms. Catalina Jones B.A. (Age 38)Chief of Staff & Sustainability More ExecutivesKey CompetitorsBenson HillNYSE:BHILTupperware BrandsNYSE:TUPGrove CollaborativeNYSE:GROVTop Wealth GroupNASDAQ:TWGLee EnterprisesNYSE:LEEView All Competitors MLEC Stock Analysis - Frequently Asked Questions Should I buy or sell Moolec Science stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Moolec Science in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MLEC shares. View MLEC analyst ratings or view top-rated stocks. What is Moolec Science's stock price target for 2024? 3 Wall Street analysts have issued twelve-month target prices for Moolec Science's shares. Their MLEC share price targets range from $5.00 to $6.00. On average, they expect the company's share price to reach $5.50 in the next year. This suggests a possible upside of 307.3% from the stock's current price. View analysts price targets for MLEC or view top-rated stocks among Wall Street analysts. How have MLEC shares performed in 2024? Moolec Science's stock was trading at $2.46 on January 1st, 2024. Since then, MLEC shares have decreased by 45.1% and is now trading at $1.3504. View the best growth stocks for 2024 here. Are investors shorting Moolec Science? Moolec Science saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 8,000 shares, an increase of 56.9% from the March 31st total of 5,100 shares. Based on an average daily volume of 1,360,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.1% of the shares of the company are sold short. View Moolec Science's Short Interest. When is Moolec Science's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024. View our MLEC earnings forecast. How were Moolec Science's earnings last quarter? Moolec Science SA (NASDAQ:MLEC) released its earnings results on Wednesday, March, 13th. The company reported ($0.05) EPS for the quarter, meeting analysts' consensus estimates of ($0.05). The business had revenue of $0.25 million for the quarter, compared to the consensus estimate of $0.63 million. How do I buy shares of Moolec Science? Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MLEC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moolec Science SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
